Business
ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
EINDHOVEN, the Netherlands, April 01, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026. The resolutions proposed by the Board, to be submitted for adoptio
About this update from Onward Medical N.v.
[{"type":"image","alt":"ONWARD Medical NV","displaySize":"","headline":null,"caption":"ONWARD Medical NV","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/ff435d5a4437f6b633ad80dab68096d0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/k5H42ENtwWiIFVl5nWlEJQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMA--/https://media.zenfs.com/en/globenewswire.com/ff435d5a4437f6b633ad80dab68096d0","width":300,"height":150}},"lazy":false},{"type":"text","content":"EINDHOVEN, the Netherlands, April 01, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today convened the 2026 Annual General Meeting of Shareholders (AGM), which will be held in Amsterdam, the Netherlands, on May 13, 2026.","length":433,"tagName":"p"},{"type":"text","content":"The resolutions proposed by the Board, to be submitted for adoption at the AGM, are as follows:","length":95,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Discussion of the annual report over the financial year 2025 (discussion item)","length":93,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adoption of the annual accounts over the financial year 2025 (voting item)","length":89,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Implementation of the compensation policy over the financial year 2025 (advisory non-binding voting item)","length":130,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Explanation of the dividend and reservation policy (discussion item)","length":78,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Release of the directors from liability for the exercise of their duties during the financial year 2025 (voting item)","length":132,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Instruction of EY Accountants B.V. as the Company's external auditor for the financial year 2026 (voting item)","length":154,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Re-appointment of Kristi...